TY - JOUR AU - Dirlikov, E. AU - Raviglione, M. AU - Scano, F. PY - 2015 DA - 2015// TI - Global tuberculosis control: toward the 2015 targets and beyond JO - Ann Intern Med VL - 163 UR - https://doi.org/10.7326/M14-2210 DO - 10.7326/M14-2210 ID - Dirlikov2015 ER - TY - STD TI - World Health Organization. Sixty-Second World Health Assembly. 2009. http://apps.who.int/gb/ebwha/pdf_files/WHA62-REC1/WHA62_REC1-en.pdf. Accessed 7 Mar 2016. UR - http://apps.who.int/gb/ebwha/pdf_files/WHA62-REC1/WHA62_REC1-en.pdf ID - ref2 ER - TY - STD TI - World Health Organization. Global Tuberculosis Report 2015. 2015. http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1. Accessed 12 Nov 2015. UR - http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1 ID - ref3 ER - TY - STD TI - World Health Organization. Uzbekistan, Tuberculosis Profile. 2015. https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=UZ&LAN=EN&outtype=html. Accessed 18 Jan 2016. UR - https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=UZ&LAN=EN&outtype=html ID - ref4 ER - TY - STD TI - Ulmasova DJ, Uzakova G, Tillyashayhov MN, et al. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011. Euro Surveill. 2013;18(42). pii: 20609. ID - ref5 ER - TY - JOUR AU - Deun, A. AU - Maug, A. K. AU - Salim, M. A. PY - 2010 DA - 2010// TI - Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis JO - Am J Respir Crit Care Med VL - 182 UR - https://doi.org/10.1164/rccm.201001-0077OC DO - 10.1164/rccm.201001-0077OC ID - Deun2010 ER - TY - JOUR AU - Piubello, A. AU - Harouna, S. H. AU - Souleymane, M. B. PY - 2014 DA - 2014// TI - High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses JO - Int J Tuberc Lung Dis VL - 18 UR - https://doi.org/10.5588/ijtld.13.0075 DO - 10.5588/ijtld.13.0075 ID - Piubello2014 ER - TY - JOUR AU - Kuaban, C. AU - Noeske, J. AU - Rieder, H. L. AU - Ait-Khaled, N. AU - Abena Foe, J. L. AU - Trebucq, A. PY - 2015 DA - 2015// TI - High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon JO - Int J Tuberc Lung Dis VL - 19 UR - https://doi.org/10.5588/ijtld.14.0535 DO - 10.5588/ijtld.14.0535 ID - Kuaban2015 ER - TY - JOUR AU - Aung, K. J. AU - Deun, A. AU - Declercq, E. PY - 2014 DA - 2014// TI - Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients JO - Int J Tuberc Lung Dis VL - 18 UR - https://doi.org/10.5588/ijtld.14.0100 DO - 10.5588/ijtld.14.0100 ID - Aung2014 ER - TY - STD TI - World Health Organization. The Shorter MDR-TB Regimen. 2016. http://www.who.int/tb/Short_MDR_regimen_factsheet.pdf. Accessed 8 June 2016. UR - http://www.who.int/tb/Short_MDR_regimen_factsheet.pdf ID - ref10 ER - TY - STD TI - World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis. 2016. http://www.who.int/tb/MDRTBguidelines2016.pdf. Accessed 9 June 2016. UR - http://www.who.int/tb/MDRTBguidelines2016.pdf ID - ref11 ER - TY - JOUR AU - Nunn, A. J. AU - Rusen, I. D. AU - Deun, A. PY - 2014 DA - 2014// TI - Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial JO - Trials VL - 15 UR - https://doi.org/10.1186/1745-6215-15-353 DO - 10.1186/1745-6215-15-353 ID - Nunn2014 ER - TY - STD TI - du Cros P, Khamraev AK, Mirzagalib T, et al. Research Protocol - Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan. 2014. http://hdl.handle.net/10144/322296. Accessed 18 Jan 2016. UR - http://hdl.handle.net/10144/322296 ID - ref13 ER - TY - JOUR AU - Trauer, J. M. AU - Denholm, J. T. AU - McBryde, E. S. PY - 2014 DA - 2014// TI - Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific JO - J Theor Biol VL - 358 UR - https://doi.org/10.1016/j.jtbi.2014.05.023 DO - 10.1016/j.jtbi.2014.05.023 ID - Trauer2014 ER - TY - JOUR AU - Ragonnet, R. AU - Trauer, J. M. AU - Denholm, J. T. AU - Geard, N. L. AU - Hellard, M. AU - McBryde, E. S. PY - 2015 DA - 2015// TI - Vaccination programs for endemic infections: modelling real versus apparent impacts of vaccine and infection characteristics JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep15468 DO - 10.1038/srep15468 ID - Ragonnet2015 ER - TY - JOUR AU - Trauer, J. M. AU - Denholm, J. T. AU - Waseem, S. AU - Ragonnet, R. AU - McBryde, E. S. PY - 2016 DA - 2016// TI - Scenario analysis for programmatic tuberculosis control in Western Province, Papua New Guinea JO - Am J Epidemiol VL - 183 UR - https://doi.org/10.1093/aje/kwv323 DO - 10.1093/aje/kwv323 ID - Trauer2016 ER - TY - STD TI - World Health Organization. Companion Handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: WHO; 2014. http://www.who.int/tb/publications/pmdt_companionhandbook/en/. Accessed 15th Oct 2016. UR - http://www.who.int/tb/publications/pmdt_companionhandbook/en/ ID - ref17 ER - TY - JOUR AU - Pooran, A. AU - Pieterson, E. AU - Davids, M. AU - Theron, G. AU - Dheda, K. PY - 2013 DA - 2013// TI - What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0054587 DO - 10.1371/journal.pone.0054587 ID - Pooran2013 ER - TY - STD TI - World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. 2011. http://apps.who.int/iris/bitstream/10665/44597/1/9789241501583_eng.pdf. Accessed 26 Nov 2015. UR - http://apps.who.int/iris/bitstream/10665/44597/1/9789241501583_eng.pdf ID - ref19 ER - TY - JOUR AU - Orenstein, E. W. AU - Basu, S. AU - Shah, N. S. PY - 2009 DA - 2009// TI - Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis JO - Lancet Infect Dis VL - 9 UR - https://doi.org/10.1016/S1473-3099(09)70041-6 DO - 10.1016/S1473-3099(09)70041-6 ID - Orenstein2009 ER - TY - JOUR AU - Diacon, A. H. AU - Pym, A. AU - Grobusch, M. P. PY - 2014 DA - 2014// TI - Multidrug-resistant tuberculosis and culture conversion with bedaquiline JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1313865 DO - 10.1056/NEJMoa1313865 ID - Diacon2014 ER - TY - JOUR AU - Gler, M. T. AU - Skripconoka, V. AU - Sanchez-Garavito, E. PY - 2012 DA - 2012// TI - Delamanid for multidrug-resistant pulmonary tuberculosis JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1112433 DO - 10.1056/NEJMoa1112433 ID - Gler2012 ER - TY - STD TI - World Health Organization. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis. 2013. http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf?ua=1. Accessed 27 Nov 2015. UR - http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf?ua=1 ID - ref23 ER - TY - JOUR AU - Dawson, R. AU - Diacon, A. H. AU - Everitt, D. PY - 2015 DA - 2015// TI - Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)62002-X DO - 10.1016/S0140-6736(14)62002-X ID - Dawson2015 ER - TY - STD TI - ClinicalTrials.gov. A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis. 2015. https://clinicaltrials.gov/ct2/show/NCT02333799. Accessed 31 Jan 2016. UR - https://clinicaltrials.gov/ct2/show/NCT02333799 ID - ref25 ER - TY - STD TI - ClinicalTrials.gov. Shortening Treatment by Advancing Novel Drugs (STAND). 2014. https://clinicaltrials.gov/ct2/show/NCT02342886?term=NCT02342886&rank=1. Accessed 31 Jan 2016. UR - https://clinicaltrials.gov/ct2/show/NCT02342886?term=NCT02342886&rank=1 ID - ref26 ER - TY - STD TI - ClinicalTrials.gov. The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB (STREAM). 2015. https://clinicaltrials.gov/ct2/show/NCT02409290. Accessed 31 Jan 2016. UR - https://clinicaltrials.gov/ct2/show/NCT02409290 ID - ref27 ER - TY - JOUR AU - Fox, G. J. AU - Barry, S. E. AU - Britton, W. J. AU - Marks, G. B. PY - 2013 DA - 2013// TI - Contact investigation for tuberculosis: a systematic review and meta-analysis JO - Eur Respir J VL - 41 UR - https://doi.org/10.1183/09031936.00070812 DO - 10.1183/09031936.00070812 ID - Fox2013 ER - TY - JOUR AU - Sekandi, J. N. AU - Neuhauser, D. AU - Smyth, K. AU - Whalen, C. C. PY - 2009 DA - 2009// TI - Active case finding of undetected tuberculosis among chronic coughers in a slum setting in Kampala, Uganda JO - Int J Tuberc Lung Dis VL - 13 ID - Sekandi2009 ER - TY - JOUR AU - Lutge, E. AU - Lewin, S. AU - Volmink, J. AU - Friedman, I. AU - Lombard, C. PY - 2013 DA - 2013// TI - Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial JO - Trials VL - 14 UR - https://doi.org/10.1186/1745-6215-14-154 DO - 10.1186/1745-6215-14-154 ID - Lutge2013 ER - TY - JOUR AU - Marlowe, E. M. AU - Novak-Weekley, S. M. AU - Cumpio, J. PY - 2011 DA - 2011// TI - Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens JO - J Clin Microbiol VL - 49 UR - https://doi.org/10.1128/JCM.02214-10 DO - 10.1128/JCM.02214-10 ID - Marlowe2011 ER - TY - JOUR AU - Boehme, C. C. AU - Nabeta, P. AU - Hillemann, D. PY - 2010 DA - 2010// TI - Rapid molecular detection of tuberculosis and rifampin resistance JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0907847 DO - 10.1056/NEJMoa0907847 ID - Boehme2010 ER -